Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SOMATROPIN Cause Concomitant disease aggravated? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Concomitant disease aggravated have been filed in association with SOMATROPIN (Nutropin AQ NuSpin 10). This represents 0.0% of all adverse event reports for SOMATROPIN.

11
Reports of Concomitant disease aggravated with SOMATROPIN
0.0%
of all SOMATROPIN reports
1
Deaths
4
Hospitalizations

How Dangerous Is Concomitant disease aggravated From SOMATROPIN?

Of the 11 reports, 1 (9.1%) resulted in death, 4 (36.4%) required hospitalization.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SOMATROPIN. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does SOMATROPIN Cause?

Drug dose omission by device (15,921) Device leakage (9,113) Device breakage (7,761) Device mechanical issue (6,411) Device information output issue (5,220) Device issue (5,131) Wrong technique in device usage process (4,746) Injection site pain (4,009) Poor quality device used (3,162) Device use error (2,801)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) MACITENTAN (286) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123)

Which SOMATROPIN Alternatives Have Lower Concomitant disease aggravated Risk?

SOMATROPIN vs SONIDEGIB SOMATROPIN vs SORAFENIB SOMATROPIN vs SORGHUM HALEPENSE POLLEN SOMATROPIN vs SOTAGLIFLOZIN SOMATROPIN vs SOTALOL

Related Pages

SOMATROPIN Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated SOMATROPIN Demographics